11 patients were diagnosed as DLBCL immunohistochemically, including 4 patients confirmed as double expression (BCL-2 and MYC) DLBCL and one patient (P10) confirmed as triple hit lymphoma (THL) by further analysis of fluorescence in situ hybridization (FISH). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.